|
FR2046920B1
(enExample)
|
1969-06-19 |
1974-05-03 |
Citizen Watch Co Ltd |
|
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3546806C2
(enExample)
|
1985-03-30 |
1991-03-28 |
Marc Genf/Geneve Ch Ballivet |
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク，インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
GB8826530D0
(en)
|
1988-11-12 |
1988-12-14 |
Ped Capacitors Ltd |
Electrical capacitors
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US20030229208A1
(en)
|
1988-12-28 |
2003-12-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
CA2057923A1
(en)
|
1989-05-16 |
1990-11-17 |
William D. Huse |
Co-expression of heteromeric receptors
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
AU8505191A
(en)
|
1990-08-24 |
1992-03-17 |
Ixsys, Inc. |
Methods of synthesizing oligonucleotides with random codons
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
JP2938569B2
(ja)
|
1990-08-29 |
1999-08-23 |
ジェンファーム インターナショナル，インコーポレイティド |
異種免疫グロブリンを作る方法及びトランスジェニックマウス
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
WO1992011272A1
(en)
|
1990-12-20 |
1992-07-09 |
Ixsys, Inc. |
Optimization of binding proteins
|
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
|
WO1993011236A1
(en)
|
1991-12-02 |
1993-06-10 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
|
WO1993011794A1
(en)
|
1991-12-13 |
1993-06-24 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
AU3737893A
(en)
|
1992-03-05 |
1993-10-05 |
Board Of Regents, The University Of Texas System |
Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
|
|
US20030148406A1
(en)
|
1992-03-17 |
2003-08-07 |
David John King |
Multivalent antigen-binding proteins
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
AU6132994A
(en)
|
1993-02-02 |
1994-08-29 |
Scripps Research Institute, The |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
WO1994029351A2
(en)
|
1993-06-16 |
1994-12-22 |
Celltech Limited |
Antibodies
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
DE69637481T2
(de)
|
1995-04-27 |
2009-04-09 |
Amgen Fremont Inc. |
Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
US7264963B1
(en)
|
1995-08-18 |
2007-09-04 |
Morphosys Ag |
Protein(poly)peptide libraries
|
|
ES2176484T3
(es)
|
1995-08-18 |
2002-12-01 |
Morphosys Ag |
Bancos de proteinas/(poli)peptidos.
|
|
JP2002514895A
(ja)
|
1995-09-28 |
2002-05-21 |
アレクション、ファーマスーティカルズ、インコーポレーテッド |
ブタ細胞相互作用タンパク質
|
|
US6331431B1
(en)
|
1995-11-28 |
2001-12-18 |
Ixsys, Inc. |
Vacuum device and method for isolating periplasmic fraction from cells
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
ES2301183T3
(es)
|
1996-12-03 |
2008-06-16 |
Amgen Fremont Inc. |
Anticuerpo completamente humano que se une al receptor del egfr.
|
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
|
WO1999006834A2
(en)
|
1997-08-04 |
1999-02-11 |
Ixsys, Incorporated |
Methods for identifying ligand specific binding molecules
|
|
CA2354862A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
ATE482275T1
(de)
|
1999-07-02 |
2010-10-15 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
IT1307309B1
(it)
|
1999-12-30 |
2001-10-30 |
Enea Ente Nuove Tec |
Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
|
|
AU5697001A
(en)
|
2000-03-31 |
2001-10-15 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
DE10037759A1
(de)
|
2000-08-03 |
2002-07-04 |
Gruenenthal Gmbh |
Screeningverfahren
|
|
EP1998266A3
(en)
|
2001-02-19 |
2009-02-11 |
Merck Patent GmbH |
Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
|
|
US20030087250A1
(en)
|
2001-03-14 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
RU2316349C2
(ru)
|
2001-05-02 |
2008-02-10 |
Пердью Рисерч Фаундейшн |
Лечение и диагностика заболеваний, опосредованных макрофагами
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
WO2003074704A1
(fr)
|
2002-03-01 |
2003-09-12 |
Japan Envirochemicals, Ltd. |
Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation
|
|
EP2090591A3
(en)
|
2002-04-22 |
2009-10-28 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
AU2003295411A1
(en)
|
2002-11-07 |
2004-06-03 |
Celltech R & D |
Human monoclonal antibodies to heparanase
|
|
KR20050059332A
(ko)
|
2002-11-07 |
2005-06-17 |
이뮤노젠 아이엔씨 |
항-씨디33 항체와 이를 이용한 급성 골수성 백혈병의치료방법
|
|
EP1481993A1
(en)
|
2003-05-28 |
2004-12-01 |
Xerion Pharmaceuticals AG |
Modulation of the poliovirus receptor function
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
KR101412271B1
(ko)
|
2003-05-09 |
2014-06-25 |
듀크 유니버시티 |
Ｃｄ２０-특이적 항체 및 이를 이용한 방법
|
|
MX342007B
(es)
|
2003-05-14 |
2016-09-09 |
Immunogen Inc |
Composicion de farmaco conjugado.
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
MXPA05014153A
(es)
|
2003-07-02 |
2006-07-03 |
Genentech Inc |
Composiciones y metodoso para el diagnostico y tratamiento de tumor.
|
|
WO2005054469A1
(en)
|
2003-12-05 |
2005-06-16 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health |
Anti-sars monoclonal antibodies
|
|
WO2005080431A2
(en)
*
|
2004-02-12 |
2005-09-01 |
Morphotek, Inc. |
Monoclonal antibodies that specifically bind to folate receptor alpha
|
|
US20080187954A1
(en)
|
2004-03-10 |
2008-08-07 |
Lonza Ltd. |
Method For Producing Antibodies
|
|
EP2259063B1
(en)
|
2004-04-27 |
2012-05-23 |
Galapagos N.V. |
Compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
|
AU2005279347A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US7780963B2
(en)
|
2004-10-25 |
2010-08-24 |
Merck & Co., Inc. |
Anti-ADDL antibodies and uses thereof
|
|
EP2562259B1
(en)
|
2004-12-21 |
2016-07-06 |
Monsanto Technology LLC |
Transgenic plants with enhanced agronomic traits
|
|
US20080181888A1
(en)
|
2004-12-31 |
2008-07-31 |
Ambrose Christine M |
Polypeptides That Bind Br3 and Uses Thereof
|
|
EP1850866A4
(en)
|
2005-01-27 |
2009-07-08 |
Univ California |
MONOCLONAL THERAPEUTIC ANTIBODIES FOR THE NEUTRALIZATION OF BOTULIN NEUROTOXINES
|
|
CA2602777C
(en)
|
2005-03-25 |
2018-12-11 |
Tolerrx, Inc. |
Gitr binding molecules and uses therefor
|
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
|
WO2006105141A1
(en)
|
2005-03-30 |
2006-10-05 |
Purdue Research Foundation |
Method for cancer prognosis using cellular folate vitamin receptor quantification
|
|
JP2009521206A
(ja)
*
|
2005-04-22 |
2009-06-04 |
モルフォテック、インク． |
免疫エフェクター活性を有する葉酸受容体アルファ陽性細胞に内部移行する抗体
|
|
EP1888639A1
(en)
|
2005-05-12 |
2008-02-20 |
Oncotherapy Science, Inc. |
Methods for damaging cells using effector function of anti-dsc2 antibody
|
|
AU2006249087B2
(en)
|
2005-05-20 |
2012-05-17 |
Lonza Biologics Plc |
High-level expression of recombinant antibody in a mammalian host cell
|
|
JP2009508467A
(ja)
|
2005-05-24 |
2009-03-05 |
アベスタゲン リミテッド |
Ｂ細胞リンパ腫の治療のためのｃｄ２０に対するモノクローナル抗体を生成する方法
|
|
WO2007006041A2
(en)
|
2005-07-05 |
2007-01-11 |
Purdue Research Foundation |
Imaging and therapeutic method using monocytes
|
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
US8124076B2
(en)
|
2005-08-18 |
2012-02-28 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against β-amyloid peptide
|
|
ES2543341T3
(es)
|
2005-09-13 |
2015-08-18 |
National Research Council Of Canada |
Métodos y composiciones para modular la actividad de células tumorales
|
|
US20070099251A1
(en)
|
2005-10-17 |
2007-05-03 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
EP3441403A1
(en)
|
2005-12-20 |
2019-02-13 |
SBI Biotech Co., Ltd. |
Anti-ilt7 antibody
|
|
US8486412B2
(en)
|
2006-06-01 |
2013-07-16 |
Mayo Foundation For Medical Education And Research |
Immunity to folate receptors
|
|
WO2007147265A1
(en)
|
2006-06-23 |
2007-12-27 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in cancer
|
|
US7910702B2
(en)
|
2006-07-28 |
2011-03-22 |
The Governors Of The University Of Alberta |
Recombinant antibodies to sclerotinia antigens
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
US20090182955A1
(en)
|
2006-09-08 |
2009-07-16 |
Rao Cherukuri |
Application configuration across client devices of a local system
|
|
EP1900752A1
(en)
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
WO2008047723A1
(fr)
|
2006-10-12 |
2008-04-24 |
Forerunner Pharma Research Co., Ltd. |
Diagnostic et traitement du cancer à l'aide d'un anticorps anti-ereg
|
|
CA2672581A1
(en)
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
|
|
KR101378302B1
(ko)
|
2006-12-20 |
2014-03-28 |
엠엠알글로벌, 인코포레이티드 |
항체 및 이들의 제조 및 사용 방법
|
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
US9216228B2
(en)
|
2007-02-16 |
2015-12-22 |
KTB Tumorforschungsgesellschaft MBM |
Receptor and antigen targeted prodrug
|
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
WO2008145136A1
(en)
|
2007-05-30 |
2008-12-04 |
Aarhus Universitet |
Stat3 inactivation by inhibition of the folate receptor pathway
|
|
US9138484B2
(en)
|
2007-06-25 |
2015-09-22 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
CN101139613B
(zh)
|
2007-08-01 |
2011-06-08 |
姜荣锡 |
抗肿瘤二元多肽及其应用与制备方法
|
|
PT2227549E
(pt)
|
2007-12-21 |
2015-10-08 |
Novartis Ag |
Sistema de seleção para cultura de células eucarióticas com base num gene de recetor de folato ligado à membrana
|
|
CA2711557A1
(en)
|
2008-01-11 |
2009-07-16 |
The University Of Tokyo |
Anti-cldn6 antibody
|
|
WO2009092014A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
MX2010011621A
(es)
|
2008-04-21 |
2011-01-14 |
Swapsol Corp |
Conversion de sulfuro de hidrogeno a hidrogeno.
|
|
WO2009132081A2
(en)
|
2008-04-24 |
2009-10-29 |
The Research Foundation Of State University Of New York |
Monoclonal antibody-based targeting of folate receptors
|
|
CN104524592B
(zh)
|
2008-04-30 |
2018-06-05 |
伊缪诺金公司 |
交联剂和它们的用途
|
|
CN102083461B
(zh)
|
2008-04-30 |
2014-09-17 |
伊缪诺金公司 |
有效的偶联物和亲水性连接体
|
|
US8383351B2
(en)
|
2008-06-11 |
2013-02-26 |
Oxford Brookes University |
Antibody to inhibin/ activin β-B subunit
|
|
US20100069298A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Robert Penny |
Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
|
|
AU2009293140A1
(en)
|
2008-09-17 |
2010-03-25 |
Endocyte, Inc. |
Folate receptor binding conjugates of antifolates
|
|
WO2010033913A1
(en)
|
2008-09-22 |
2010-03-25 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
|
CN101440130B
(zh)
|
2008-11-21 |
2011-07-27 |
中国人民解放军第四军医大学 |
一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
|
|
EP2995953B1
(en)
|
2009-03-24 |
2017-11-29 |
Biocept, Inc. |
Devices and methods of cell capture and analysis
|
|
WO2011010652A1
(ja)
*
|
2009-07-23 |
2011-01-27 |
株式会社資生堂 |
油中水型乳化化粧料
|
|
JP5769316B2
(ja)
*
|
2009-08-06 |
2015-08-26 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
WO2011100398A1
(en)
|
2010-02-10 |
2011-08-18 |
Immunogen, Inc. |
Cd20 antibodies and uses thereof
|
|
SMT201700139T1
(it)
*
|
2010-02-24 |
2017-05-08 |
Immunogen Inc |
Immunoconiugati contro il recettore 1 del folato e relativi usi
|
|
EP2629798A4
(en)
*
|
2010-10-20 |
2014-05-28 |
Morphotek Inc |
GLYCOFORMS OF ANTI-RECEPTOR ANTIBODY-ALPHA FOLATE (ANTI-FRA)
|
|
JP6224456B2
(ja)
*
|
2010-11-05 |
2017-11-01 |
モルフォテック、インク． |
葉酸受容体アルファ発現癌の診断および予後マーカーとしての葉酸受容体アルファ
|
|
EA201991268A3
(ru)
|
2011-03-29 |
2020-01-31 |
Иммуноджен, Инк. |
Получение конъюгатов "майтансиноид-антитело" одностадийным способом
|
|
CA2831562A1
(en)
|
2011-03-29 |
2012-10-04 |
Immunogen, Inc. |
Process for manufacturing conjugates of improved homogeneity
|
|
CN114441757A
(zh)
|
2011-04-01 |
2022-05-06 |
伊缪诺金公司 |
用于增加folr1癌症治疗的功效的方法
|
|
US20120282282A1
(en)
|
2011-04-04 |
2012-11-08 |
Immunogen, Inc. |
Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
|
|
JP6220333B2
(ja)
*
|
2011-07-15 |
2017-10-25 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗葉酸受容体アルファ抗体およびその使用
|
|
MX362514B
(es)
|
2012-08-31 |
2019-01-22 |
Immunogen Inc |
Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato.
|
|
EP2930240B1
(en)
|
2012-12-07 |
2018-08-01 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-folr1 antibody
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
KR20240068778A
(ko)
|
2013-05-14 |
2024-05-17 |
이뮤노젠 아이엔씨 |
항-folr1 면역접합체 투약 섭생
|
|
SG11201601037YA
(en)
|
2013-08-30 |
2016-03-30 |
Immunogen Inc |
Antibodies and assays for detection of folate receptor 1
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
SG10201907042PA
(en)
|
2013-10-08 |
2019-09-27 |
Immunogen Inc |
Anti-folr1 immunoconjugate dosing regimens
|
|
US20150297744A1
(en)
|
2014-03-28 |
2015-10-22 |
Immunogen, Inc. |
Anti-FOLR1 Immunoconjugate Dosing Regimens
|
|
JP6880006B2
(ja)
|
2015-09-17 |
2021-06-02 |
イミュノジェン， インコーポレイテッド |
抗ｆｏｌｒ１免疫複合体を含む治療組み合わせ
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|